Global Peptide CDMO Market Growth 2022-2028

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Peptide CDMO Annual Sales 2017-2028

2.1.2 World Current & Future Analysis for Peptide CDMO by Geographic Region, 2017, 2022 & 2028

2.1.3 World Current & Future Analysis for Peptide CDMO by Country/Region, 2017, 2022 & 2028

2.2 Peptide CDMO Segment by Type

2.2.1 APIs and Intermediates

2.2.2 FDF

2.3 Peptide CDMO Sales by Type

2.3.1 Global Peptide CDMO Sales Market Share by Type (2017-2022)

2.3.2 Global Peptide CDMO Revenue and Market Share by Type (2017-2022)

2.3.3 Global Peptide CDMO Sale Price by Type (2017-2022)

2.4 Peptide CDMO Segment by Application

2.4.1 Commercial

2.4.2 Academic Research

2.5 Peptide CDMO Sales by Application

2.5.1 Global Peptide CDMO Sale Market Share by Application (2017-2022)

2.5.2 Global Peptide CDMO Revenue and Market Share by Application (2017-2022)

2.5.3 Global Peptide CDMO Sale Price by Application (2017-2022)

3 Global Peptide CDMO by Company

3.1 Global Peptide CDMO Breakdown Data by Company

3.1.1 Global Peptide CDMO Annual Sales by Company (2020-2022)

3.1.2 Global Peptide CDMO Sales Market Share by Company (2020-2022)

3.2 Global Peptide CDMO Annual Revenue by Company (2020-2022)

3.2.1 Global Peptide CDMO Revenue by Company (2020-2022)

3.2.2 Global Peptide CDMO Revenue Market Share by Company (2020-2022)

3.3 Global Peptide CDMO Sale Price by Company

3.4 Key Manufacturers Peptide CDMO Producing Area Distribution, Sales Area, Product Type

3.4.1 Key Manufacturers Peptide CDMO Product Location Distribution

3.4.2 Players Peptide CDMO Products Offered

3.5 Market Concentration Rate Analysis

3.5.1 Competition Landscape Analysis

3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

3.6 New Products and Potential Entrants

3.7 Mergers & Acquisitions, Expansion

4 World Historic Review for Peptide CDMO by Geographic Region

4.1 World Historic Peptide CDMO Market Size by Geographic Region (2017-2022)

4.1.1 Global Peptide CDMO Annual Sales by Geographic Region (2017-2022)

4.1.2 Global Peptide CDMO Annual Revenue by Geographic Region

4.2 World Historic Peptide CDMO Market Size by Country/Region (2017-2022)

4.2.1 Global Peptide CDMO Annual Sales by Country/Region (2017-2022)

4.2.2 Global Peptide CDMO Annual Revenue by Country/Region

4.3 Americas Peptide CDMO Sales Growth

4.4 APAC Peptide CDMO Sales Growth

4.5 Europe Peptide CDMO Sales Growth

4.6 Middle East & Africa Peptide CDMO Sales Growth

5 Americas

5.1 Americas Peptide CDMO Sales by Country

5.1.1 Americas Peptide CDMO Sales by Country (2017-2022)

5.1.2 Americas Peptide CDMO Revenue by Country (2017-2022)

5.2 Americas Peptide CDMO Sales by Type

5.3 Americas Peptide CDMO Sales by Application

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC Peptide CDMO Sales by Region

6.1.1 APAC Peptide CDMO Sales by Region (2017-2022)

6.1.2 APAC Peptide CDMO Revenue by Region (2017-2022)

6.2 APAC Peptide CDMO Sales by Type

6.3 APAC Peptide CDMO Sales by Application

6.4 China

6.5 Japan

6.6 South Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

6.10 China Taiwan

7 Europe

7.1 Europe Peptide CDMO by Country

7.1.1 Europe Peptide CDMO Sales by Country (2017-2022)

7.1.2 Europe Peptide CDMO Revenue by Country (2017-2022)

7.2 Europe Peptide CDMO Sales by Type

7.3 Europe Peptide CDMO Sales by Application

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa Peptide CDMO by Country

8.1.1 Middle East & Africa Peptide CDMO Sales by Country (2017-2022)

8.1.2 Middle East & Africa Peptide CDMO Revenue by Country (2017-2022)

8.2 Middle East & Africa Peptide CDMO Sales by Type

8.3 Middle East & Africa Peptide CDMO Sales by Application

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers & Growth Opportunities

9.2 Market Challenges & Risks

9.3 Industry Trends

10 Manufacturing Cost Structure Analysis

10.1 Raw Material and Suppliers

10.2 Manufacturing Cost Structure Analysis of Peptide CDMO

10.3 Manufacturing Process Analysis of Peptide CDMO

10.4 Industry Chain Structure of Peptide CDMO

11 Marketing, Distributors and Customer

11.1 Sales Channel

11.1.1 Direct Channels

11.1.2 Indirect Channels

11.2 Peptide CDMO Distributors

11.3 Peptide CDMO Customer

12 World Forecast Review for Peptide CDMO by Geographic Region

12.1 Global Peptide CDMO Market Size Forecast by Region

12.1.1 Global Peptide CDMO Forecast by Region (2023-2028)

12.1.2 Global Peptide CDMO Annual Revenue Forecast by Region (2023-2028)

12.2 Americas Forecast by Country

12.3 APAC Forecast by Region

12.4 Europe Forecast by Country

12.5 Middle East & Africa Forecast by Country

12.6 Global Peptide CDMO Forecast by Type

12.7 Global Peptide CDMO Forecast by Application

13 Key Players Analysis

13.1 Bachem

13.1.1 Bachem Company Information

13.1.2 Bachem Peptide CDMO Product Offered

13.1.3 Bachem Peptide CDMO Sales, Revenue, Price and Gross Margin (2020-2022)

13.1.4 Bachem Main Business Overview

13.1.5 Bachem Latest Developments

13.2 PolyPeptide

13.2.1 PolyPeptide Company Information

13.2.2 PolyPeptide Peptide CDMO Product Offered

13.2.3 PolyPeptide Peptide CDMO Sales, Revenue, Price and Gross Margin (2020-2022)

13.2.4 PolyPeptide Main Business Overview

13.2.5 PolyPeptide Latest Developments

13.3 AmbioPharm

13.3.1 AmbioPharm Company Information

13.3.2 AmbioPharm Peptide CDMO Product Offered

13.3.3 AmbioPharm Peptide CDMO Sales, Revenue, Price and Gross Margin (2020-2022)

13.3.4 AmbioPharm Main Business Overview

13.3.5 AmbioPharm Latest Developments

13.4 USV Peptides

13.4.1 USV Peptides Company Information

13.4.2 USV Peptides Peptide CDMO Product Offered

13.4.3 USV Peptides Peptide CDMO Sales, Revenue, Price and Gross Margin (2020-2022)

13.4.4 USV Peptides Main Business Overview

13.4.5 USV Peptides Latest Developments

13.5 Thermo Fisher

13.5.1 Thermo Fisher Company Information

13.5.2 Thermo Fisher Peptide CDMO Product Offered

13.5.3 Thermo Fisher Peptide CDMO Sales, Revenue, Price and Gross Margin (2020-2022)

13.5.4 Thermo Fisher Main Business Overview

13.5.5 Thermo Fisher Latest Developments

13.6 Bio Basic

13.6.1 Bio Basic Company Information

13.6.2 Bio Basic Peptide CDMO Product Offered

13.6.3 Bio Basic Peptide CDMO Sales, Revenue, Price and Gross Margin (2020-2022)

13.6.4 Bio Basic Main Business Overview

13.6.5 Bio Basic Latest Developments

13.7 JPT

13.7.1 JPT Company Information

13.7.2 JPT Peptide CDMO Product Offered

13.7.3 JPT Peptide CDMO Sales, Revenue, Price and Gross Margin (2020-2022)

13.7.4 JPT Main Business Overview

13.7.5 JPT Latest Developments

13.8 Genscript

13.8.1 Genscript Company Information

13.8.2 Genscript Peptide CDMO Product Offered

13.8.3 Genscript Peptide CDMO Sales, Revenue, Price and Gross Margin (2020-2022)

13.8.4 Genscript Main Business Overview

13.8.5 Genscript Latest Developments

13.9 Xinbang Pharma

13.9.1 Xinbang Pharma Company Information

13.9.2 Xinbang Pharma Peptide CDMO Product Offered

13.9.3 Xinbang Pharma Peptide CDMO Sales, Revenue, Price and Gross Margin (2020-2022)

13.9.4 Xinbang Pharma Main Business Overview

13.9.5 Xinbang Pharma Latest Developments

13.10 ScinoPharm

13.10.1 ScinoPharm Company Information

13.10.2 ScinoPharm Peptide CDMO Product Offered

13.10.3 ScinoPharm Peptide CDMO Sales, Revenue, Price and Gross Margin (2020-2022)

13.10.4 ScinoPharm Main Business Overview

13.10.5 ScinoPharm Latest Developments

13.11 SN Biopharm

13.11.1 SN Biopharm Company Information

13.11.2 SN Biopharm Peptide CDMO Product Offered

13.11.3 SN Biopharm Peptide CDMO Sales, Revenue, Price and Gross Margin (2020-2022)

13.11.4 SN Biopharm Main Business Overview

13.11.5 SN Biopharm Latest Developments

13.12 CBL

13.12.1 CBL Company Information

13.12.2 CBL Peptide CDMO Product Offered

13.12.3 CBL Peptide CDMO Sales, Revenue, Price and Gross Margin (2020-2022)

13.12.4 CBL Main Business Overview

13.12.5 CBL Latest Developments

13.13 Piramal Pharma

13.13.1 Piramal Pharma Company Information

13.13.2 Piramal Pharma Peptide CDMO Product Offered

13.13.3 Piramal Pharma Peptide CDMO Sales, Revenue, Price and Gross Margin (2020-2022)

13.13.4 Piramal Pharma Main Business Overview

13.13.5 Piramal Pharma Latest Developments

13.14 CordenPharma

13.14.1 CordenPharma Company Information

13.14.2 CordenPharma Peptide CDMO Product Offered

13.14.3 CordenPharma Peptide CDMO Sales, Revenue, Price and Gross Margin (2020-2022)

13.14.4 CordenPharma Main Business Overview

13.14.5 CordenPharma Latest Developments

13.15 CPC Scientific

13.15.1 CPC Scientific Company Information

13.15.2 CPC Scientific Peptide CDMO Product Offered

13.15.3 CPC Scientific Peptide CDMO Sales, Revenue, Price and Gross Margin (2020-2022)

13.15.4 CPC Scientific Main Business Overview

13.15.5 CPC Scientific Latest Developments

14 Research Findings and Conclusion

Table 1. Peptide CDMO Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)

Table 2. Peptide CDMO Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)

Table 3. Major Players of APIs and Intermediates

Table 4. Major Players of FDF

Table 5. Global Peptide CDMO Sales by Type (2017-2022) & (Tons)

Table 6. Global Peptide CDMO Sales Market Share by Type (2017-2022)

Table 7. Global Peptide CDMO Revenue by Type (2017-2022) & ($ million)

Table 8. Global Peptide CDMO Revenue Market Share by Type (2017-2022)

Table 9. Global Peptide CDMO Sale Price by Type (2017-2022) & (US$/Ton)

Table 10. Global Peptide CDMO Sales by Application (2017-2022) & (Tons)

Table 11. Global Peptide CDMO Sales Market Share by Application (2017-2022)

Table 12. Global Peptide CDMO Revenue by Application (2017-2022)

Table 13. Global Peptide CDMO Revenue Market Share by Application (2017-2022)

Table 14. Global Peptide CDMO Sale Price by Application (2017-2022) & (US$/Ton)

Table 15. Global Peptide CDMO Sales by Company (2020-2022) & (Tons)

Table 16. Global Peptide CDMO Sales Market Share by Company (2020-2022)

Table 17. Global Peptide CDMO Revenue by Company (2020-2022) ($ Millions)

Table 18. Global Peptide CDMO Revenue Market Share by Company (2020-2022)

Table 19. Global Peptide CDMO Sale Price by Company (2020-2022) & (US$/Ton)

Table 20. Key Manufacturers Peptide CDMO Producing Area Distribution and Sales Area

Table 21. Players Peptide CDMO Products Offered

Table 22. Peptide CDMO Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

Table 23. New Products and Potential Entrants

Table 24. Mergers & Acquisitions, Expansion

Table 25. Global Peptide CDMO Sales by Geographic Region (2017-2022) & (Tons)

Table 26. Global Peptide CDMO Sales Market Share Geographic Region (2017-2022)

Table 27. Global Peptide CDMO Revenue by Geographic Region (2017-2022) & ($ millions)

Table 28. Global Peptide CDMO Revenue Market Share by Geographic Region (2017-2022)

Table 29. Global Peptide CDMO Sales by Country/Region (2017-2022) & (Tons)

Table 30. Global Peptide CDMO Sales Market Share by Country/Region (2017-2022)

Table 31. Global Peptide CDMO Revenue by Country/Region (2017-2022) & ($ millions)

Table 32. Global Peptide CDMO Revenue Market Share by Country/Region (2017-2022)

Table 33. Americas Peptide CDMO Sales by Country (2017-2022) & (Tons)

Table 34. Americas Peptide CDMO Sales Market Share by Country (2017-2022)

Table 35. Americas Peptide CDMO Revenue by Country (2017-2022) & ($ Millions)

Table 36. Americas Peptide CDMO Revenue Market Share by Country (2017-2022)

Table 37. Americas Peptide CDMO Sales by Type (2017-2022) & (Tons)

Table 38. Americas Peptide CDMO Sales Market Share by Type (2017-2022)

Table 39. Americas Peptide CDMO Sales by Application (2017-2022) & (Tons)

Table 40. Americas Peptide CDMO Sales Market Share by Application (2017-2022)

Table 41. APAC Peptide CDMO Sales by Region (2017-2022) & (Tons)

Table 42. APAC Peptide CDMO Sales Market Share by Region (2017-2022)

Table 43. APAC Peptide CDMO Revenue by Region (2017-2022) & ($ Millions)

Table 44. APAC Peptide CDMO Revenue Market Share by Region (2017-2022)

Table 45. APAC Peptide CDMO Sales by Type (2017-2022) & (Tons)

Table 46. APAC Peptide CDMO Sales Market Share by Type (2017-2022)

Table 47. APAC Peptide CDMO Sales by Application (2017-2022) & (Tons)

Table 48. APAC Peptide CDMO Sales Market Share by Application (2017-2022)

Table 49. Europe Peptide CDMO Sales by Country (2017-2022) & (Tons)

Table 50. Europe Peptide CDMO Sales Market Share by Country (2017-2022)

Table 51. Europe Peptide CDMO Revenue by Country (2017-2022) & ($ Millions)

Table 52. Europe Peptide CDMO Revenue Market Share by Country (2017-2022)

Table 53. Europe Peptide CDMO Sales by Type (2017-2022) & (Tons)

Table 54. Europe Peptide CDMO Sales Market Share by Type (2017-2022)

Table 55. Europe Peptide CDMO Sales by Application (2017-2022) & (Tons)

Table 56. Europe Peptide CDMO Sales Market Share by Application (2017-2022)

Table 57. Middle East & Africa Peptide CDMO Sales by Country (2017-2022) & (Tons)

Table 58. Middle East & Africa Peptide CDMO Sales Market Share by Country (2017-2022)

Table 59. Middle East & Africa Peptide CDMO Revenue by Country (2017-2022) & ($ Millions)

Table 60. Middle East & Africa Peptide CDMO Revenue Market Share by Country (2017-2022)

Table 61. Middle East & Africa Peptide CDMO Sales by Type (2017-2022) & (Tons)

Table 62. Middle East & Africa Peptide CDMO Sales Market Share by Type (2017-2022)

Table 63. Middle East & Africa Peptide CDMO Sales by Application (2017-2022) & (Tons)

Table 64. Middle East & Africa Peptide CDMO Sales Market Share by Application (2017-2022)

Table 65. Key Market Drivers & Growth Opportunities of Peptide CDMO

Table 66. Key Market Challenges & Risks of Peptide CDMO

Table 67. Key Industry Trends of Peptide CDMO

Table 68. Peptide CDMO Raw Material

Table 69. Key Suppliers of Raw Materials

Table 70. Peptide CDMO Distributors List

Table 71. Peptide CDMO Customer List

Table 72. Global Peptide CDMO Sales Forecast by Region (2023-2028) & (Tons)

Table 73. Global Peptide CDMO Sales Market Forecast by Region

Table 74. Global Peptide CDMO Revenue Forecast by Region (2023-2028) & ($ millions)

Table 75. Global Peptide CDMO Revenue Market Share Forecast by Region (2023-2028)

Table 76. Americas Peptide CDMO Sales Forecast by Country (2023-2028) & (Tons)

Table 77. Americas Peptide CDMO Revenue Forecast by Country (2023-2028) & ($ millions)

Table 78. APAC Peptide CDMO Sales Forecast by Region (2023-2028) & (Tons)

Table 79. APAC Peptide CDMO Revenue Forecast by Region (2023-2028) & ($ millions)

Table 80. Europe Peptide CDMO Sales Forecast by Country (2023-2028) & (Tons)

Table 81. Europe Peptide CDMO Revenue Forecast by Country (2023-2028) & ($ millions)

Table 82. Middle East & Africa Peptide CDMO Sales Forecast by Country (2023-2028) & (Tons)

Table 83. Middle East & Africa Peptide CDMO Revenue Forecast by Country (2023-2028) & ($ millions)

Table 84. Global Peptide CDMO Sales Forecast by Type (2023-2028) & (Tons)

Table 85. Global Peptide CDMO Sales Market Share Forecast by Type (2023-2028)

Table 86. Global Peptide CDMO Revenue Forecast by Type (2023-2028) & ($ Millions)

Table 87. Global Peptide CDMO Revenue Market Share Forecast by Type (2023-2028)

Table 88. Global Peptide CDMO Sales Forecast by Application (2023-2028) & (Tons)

Table 89. Global Peptide CDMO Sales Market Share Forecast by Application (2023-2028)

Table 90. Global Peptide CDMO Revenue Forecast by Application (2023-2028) & ($ Millions)

Table 91. Global Peptide CDMO Revenue Market Share Forecast by Application (2023-2028)

Table 92. Bachem Basic Information, Peptide CDMO Manufacturing Base, Sales Area and Its Competitors

Table 93. Bachem Peptide CDMO Product Offered

Table 94. Bachem Peptide CDMO Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2020-2022)

Table 95. Bachem Main Business

Table 96. Bachem Latest Developments

Table 97. PolyPeptide Basic Information, Peptide CDMO Manufacturing Base, Sales Area and Its Competitors

Table 98. PolyPeptide Peptide CDMO Product Offered

Table 99. PolyPeptide Peptide CDMO Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2020-2022)

Table 100. PolyPeptide Main Business

Table 101. PolyPeptide Latest Developments

Table 102. AmbioPharm Basic Information, Peptide CDMO Manufacturing Base, Sales Area and Its Competitors

Table 103. AmbioPharm Peptide CDMO Product Offered

Table 104. AmbioPharm Peptide CDMO Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2020-2022)

Table 105. AmbioPharm Main Business

Table 106. AmbioPharm Latest Developments

Table 107. USV Peptides Basic Information, Peptide CDMO Manufacturing Base, Sales Area and Its Competitors

Table 108. USV Peptides Peptide CDMO Product Offered

Table 109. USV Peptides Peptide CDMO Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2020-2022)

Table 110. USV Peptides Main Business

Table 111. USV Peptides Latest Developments

Table 112. Thermo Fisher Basic Information, Peptide CDMO Manufacturing Base, Sales Area and Its Competitors

Table 113. Thermo Fisher Peptide CDMO Product Offered

Table 114. Thermo Fisher Peptide CDMO Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2020-2022)

Table 115. Thermo Fisher Main Business

Table 116. Thermo Fisher Latest Developments

Table 117. Bio Basic Basic Information, Peptide CDMO Manufacturing Base, Sales Area and Its Competitors

Table 118. Bio Basic Peptide CDMO Product Offered

Table 119. Bio Basic Peptide CDMO Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2020-2022)

Table 120. Bio Basic Main Business

Table 121. Bio Basic Latest Developments

Table 122. JPT Basic Information, Peptide CDMO Manufacturing Base, Sales Area and Its Competitors

Table 123. JPT Peptide CDMO Product Offered

Table 124. JPT Peptide CDMO Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2020-2022)

Table 125. JPT Main Business

Table 126. JPT Latest Developments

Table 127. Genscript Basic Information, Peptide CDMO Manufacturing Base, Sales Area and Its Competitors

Table 128. Genscript Peptide CDMO Product Offered

Table 129. Genscript Peptide CDMO Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2020-2022)

Table 130. Genscript Main Business

Table 131. Genscript Latest Developments

Table 132. Xinbang Pharma Basic Information, Peptide CDMO Manufacturing Base, Sales Area and Its Competitors

Table 133. Xinbang Pharma Peptide CDMO Product Offered

Table 134. Xinbang Pharma Peptide CDMO Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2020-2022)

Table 135. Xinbang Pharma Main Business

Table 136. Xinbang Pharma Latest Developments

Table 137. ScinoPharm Basic Information, Peptide CDMO Manufacturing Base, Sales Area and Its Competitors

Table 138. ScinoPharm Peptide CDMO Product Offered

Table 139. ScinoPharm Peptide CDMO Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2020-2022)

Table 140. ScinoPharm Main Business

Table 141. ScinoPharm Latest Developments

Table 142. SN Biopharm Basic Information, Peptide CDMO Manufacturing Base, Sales Area and Its Competitors

Table 143. SN Biopharm Peptide CDMO Product Offered

Table 144. SN Biopharm Peptide CDMO Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2020-2022)

Table 145. SN Biopharm Main Business

Table 146. SN Biopharm Latest Developments

Table 147. CBL Basic Information, Peptide CDMO Manufacturing Base, Sales Area and Its Competitors

Table 148. CBL Peptide CDMO Product Offered

Table 149. CBL Peptide CDMO Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2020-2022)

Table 150. CBL Main Business

Table 151. CBL Latest Developments

Table 152. Piramal Pharma Basic Information, Peptide CDMO Manufacturing Base, Sales Area and Its Competitors

Table 153. Piramal Pharma Peptide CDMO Product Offered

Table 154. Piramal Pharma Peptide CDMO Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2020-2022)

Table 155. Piramal Pharma Main Business

Table 156. Piramal Pharma Latest Developments

Table 157. CordenPharma Basic Information, Peptide CDMO Manufacturing Base, Sales Area and Its Competitors

Table 158. CordenPharma Peptide CDMO Product Offered

Table 159. CordenPharma Peptide CDMO Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2020-2022)

Table 160. CordenPharma Main Business

Table 161. CordenPharma Latest Developments

Table 162. CPC Scientific Basic Information, Peptide CDMO Manufacturing Base, Sales Area and Its Competitors

Table 163. CPC Scientific Peptide CDMO Product Offered

Table 164. CPC Scientific Peptide CDMO Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2020-2022)

Table 165. CPC Scientific Main Business

Table 166. CPC Scientific Latest Developments

List of Figures

Figure 1. Picture of Peptide CDMO

Figure 2. Peptide CDMO Report Years Considered

Figure 3. Research Objectives

Figure 4. Research Methodology

Figure 5. Research Process and Data Source

Figure 6. Global Peptide CDMO Sales Growth Rate 2017-2028 (Tons)

Figure 7. Global Peptide CDMO Revenue Growth Rate 2017-2028 ($ Millions)

Figure 8. Peptide CDMO Sales by Region (2021 & 2028) & ($ millions)

Figure 9. Product Picture of APIs and Intermediates

Figure 10. Product Picture of FDF

Figure 11. Global Peptide CDMO Sales Market Share by Type in 2021

Figure 12. Global Peptide CDMO Revenue Market Share by Type (2017-2022)

Figure 13. Peptide CDMO Consumed in Commercial

Figure 14. Global Peptide CDMO Market: Commercial (2017-2022) & (Tons)

Figure 15. Peptide CDMO Consumed in Academic Research

Figure 16. Global Peptide CDMO Market: Academic Research (2017-2022) & (Tons)

Figure 17. Global Peptide CDMO Sales Market Share by Application (2017-2022)

Figure 18. Global Peptide CDMO Revenue Market Share by Application in 2021

Figure 19. Peptide CDMO Revenue Market by Company in 2021 ($ Million)

Figure 20. Global Peptide CDMO Revenue Market Share by Company in 2021

Figure 21. Global Peptide CDMO Sales Market Share by Geographic Region (2017-2022)

Figure 22. Global Peptide CDMO Revenue Market Share by Geographic Region in 2021

Figure 23. Global Peptide CDMO Sales Market Share by Region (2017-2022)

Figure 24. Global Peptide CDMO Revenue Market Share by Country/Region in 2021

Figure 25. Americas Peptide CDMO Sales 2017-2022 (Tons)

Figure 26. Americas Peptide CDMO Revenue 2017-2022 ($ Millions)

Figure 27. APAC Peptide CDMO Sales 2017-2022 (Tons)

Figure 28. APAC Peptide CDMO Revenue 2017-2022 ($ Millions)

Figure 29. Europe Peptide CDMO Sales 2017-2022 (Tons)

Figure 30. Europe Peptide CDMO Revenue 2017-2022 ($ Millions)

Figure 31. Middle East & Africa Peptide CDMO Sales 2017-2022 (Tons)

Figure 32. Middle East & Africa Peptide CDMO Revenue 2017-2022 ($ Millions)

Figure 33. Americas Peptide CDMO Sales Market Share by Country in 2021

Figure 34. Americas Peptide CDMO Revenue Market Share by Country in 2021

Figure 35. United States Peptide CDMO Revenue Growth 2017-2022 ($ Millions)

Figure 36. Canada Peptide CDMO Revenue Growth 2017-2022 ($ Millions)

Figure 37. Mexico Peptide CDMO Revenue Growth 2017-2022 ($ Millions)

Figure 38. Brazil Peptide CDMO Revenue Growth 2017-2022 ($ Millions)

Figure 39. APAC Peptide CDMO Sales Market Share by Region in 2021

Figure 40. APAC Peptide CDMO Revenue Market Share by Regions in 2021

Figure 41. China Peptide CDMO Revenue Growth 2017-2022 ($ Millions)

Figure 42. Japan Peptide CDMO Revenue Growth 2017-2022 ($ Millions)

Figure 43. South Korea Peptide CDMO Revenue Growth 2017-2022 ($ Millions)

Figure 44. Southeast Asia Peptide CDMO Revenue Growth 2017-2022 ($ Millions)

Figure 45. India Peptide CDMO Revenue Growth 2017-2022 ($ Millions)

Figure 46. Australia Peptide CDMO Revenue Growth 2017-2022 ($ Millions)

Figure 47. Europe Peptide CDMO Sales Market Share by Country in 2021

Figure 48. Europe Peptide CDMO Revenue Market Share by Country in 2021

Figure 49. Germany Peptide CDMO Revenue Growth 2017-2022 ($ Millions)

Figure 50. France Peptide CDMO Revenue Growth 2017-2022 ($ Millions)

Figure 51. UK Peptide CDMO Revenue Growth 2017-2022 ($ Millions)

Figure 52. Italy Peptide CDMO Revenue Growth 2017-2022 ($ Millions)

Figure 53. Russia Peptide CDMO Revenue Growth 2017-2022 ($ Millions)

Figure 54. Middle East & Africa Peptide CDMO Sales Market Share by Country in 2021

Figure 55. Middle East & Africa Peptide CDMO Revenue Market Share by Country in 2021

Figure 56. Egypt Peptide CDMO Revenue Growth 2017-2022 ($ Millions)

Figure 57. South Africa Peptide CDMO Revenue Growth 2017-2022 ($ Millions)

Figure 58. Israel Peptide CDMO Revenue Growth 2017-2022 ($ Millions)

Figure 59. Turkey Peptide CDMO Revenue Growth 2017-2022 ($ Millions)

Figure 60. GCC Country Peptide CDMO Revenue Growth 2017-2022 ($ Millions)

Figure 61. Manufacturing Cost Structure Analysis of Peptide CDMO in 2021

Figure 62. Manufacturing Process Analysis of Peptide CDMO

Figure 63. Industry Chain Structure of Peptide CDMO

Figure 64. Channels of Distribution

Figure 65. Distributors Profiles